Fox Chase-Temple Health form collaboration with Accutest Research Labs in India

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FOX CHASE CANCER CENTER – Temple Health formed a partnership with Accutest Research Laboratories for joint work on clinical trials.

The partnership aims to offer a research platform to conduct clinical trials in the United States, India, Southeast Asia and Latin America. Representatives of both organizations signed a non-binding memorandum of understanding on Nov. 10 in New Delhi.

Accutest was founded in 1998, and offers end-to-end services to pharmaceutical and biotechnology companies. Its services include phase I bioavailability/bioequivalence studies, phase II – IV clinical development services and biosimilars services, covering clinical operations, clinical data management, pharmacovigilance, and medical writing services.

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login